chr19-12526991-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_144976.4(ZNF564):c.1117G>A(p.Ala373Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000403 in 1,613,826 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_144976.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ZNF564 | NM_144976.4 | c.1117G>A | p.Ala373Thr | missense_variant | 4/4 | ENST00000339282.12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ZNF564 | ENST00000339282.12 | c.1117G>A | p.Ala373Thr | missense_variant | 4/4 | 1 | NM_144976.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 151958Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000916 AC: 23AN: 251146Hom.: 0 AF XY: 0.0000810 AC XY: 11AN XY: 135866
GnomAD4 exome AF: 0.0000410 AC: 60AN: 1461868Hom.: 0 Cov.: 32 AF XY: 0.0000426 AC XY: 31AN XY: 727228
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151958Hom.: 0 Cov.: 33 AF XY: 0.0000539 AC XY: 4AN XY: 74206
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 05, 2021 | The c.1117G>A (p.A373T) alteration is located in exon 4 (coding exon 4) of the ZNF564 gene. This alteration results from a G to A substitution at nucleotide position 1117, causing the alanine (A) at amino acid position 373 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at